From the New York Times, and all the rest of “our free press”—devoted as they are to (a) maintaining panic over the coronavirus, (b) assailingChina for its handling of the epidemic, spotlighting its totalitarian secretiveness and clumsy public reassurances(so different from the open, honest CDC and WHO), and (c) attacking Trump for his mishandling of the crisis over here—you wouldn’t know that China has been diligently searching for a cure, and may have found one.
For a clear sense of the Times‘ blinding bias, check out “Beijing Battles the Blow To Its Image as a Power,” by Steven Lee Myers, whose work is surely held in very high esteem inside (if not dictated by) the CIA, as he’s an old hand at recycling Cold War propaganda. (Myers is the author of The New Tsar: The Rise and Reign of Vladimir Putin.) Under the heading “DAMAGE CONTROL,” his piece today deals only with the “intensifying authoritarianism” of XI’s crisis management, the Party’s “reflex for [sic] secrecy and obfuscation,” and the poor reviews, “around the world,” of “China’s public health standards, its one-party control,
and its suppression of dissent,” and so on, the point profusely re-affirmed by”experts” in or from the West (where, of course, dissent is not suppressed): “They have a toolbox that only seems to have a hammer,” says Jörg Wuttke, president of the European Chamber of Commerce in China (and now himself in quarantine).
What makes this propaganda isn’t that it’s simply false—China is run with an iron hand, is highly secretive, and does suppress dissent (and so sets an example that the state is emulating piecemeal over here, as Julian Assange would say if he were free to speak, undrugged). What makes Myers’ article a shot of propaganda is its incompleteness, as its leaves out what’s actually far more germane to the coronavirus crisis than the Orwellian aspects of Xi’s regime. Myers’ damning reference to “China’spublic health standards” is especially misleading, since China has been doing more than any other country to discover an effective treatment for the illness—as was reported yesterday by the Windsor Star, in “Clinical trials happening globally to halt COVID-19”:
“China, in particular, has seen a major spike in clinical trial activity in its efforts to develop a treatment, with more than 260 studies registered in the World Health Organization (WHO) InternationalClinical Trials Registry platform for COVID-19 (as of March 5, 2020.”The (unnamed) reporter then goes on to note the promising results of Favilavir, an anti-viral drug (synthesized by a Taiwanese pharmaceutical company); a blood transfusion technique under study in Shanghai; and15 trials of various traditional Chinese medicines, “including Shuang Huang Lian, a Chinese herbal medicine that contains extracts from the dried fruit lian qiao (Forsythiae fructus), which has been used for treating infections for more than 2,000 years.”
What this reporter does not mention is what seems to be the most effective treatments that the Chinese have apparently discovered: chloroquine, an anti-malarial drug, and the anti-viral drug remdesivir. The very promising results of those drugs against the coronavirus have been noted, in detail, by a team of Chinese scientists in a letter to the editors of Nature back in early February:
Since then, the effectiveness of chloroquine in particular as a cure for the coronavirus has been reconfirmed by Didier Raoult, an eminent French specialist in infection diseases, who has authored some 2,000 articles on his research. (His bio is on Wikipedia.) As Dick Atlee tells us here, Raoult’s imprimatur is especially important, since the use of chloroquine would obviate the need to rush out a new vaccine for the coronavirus, and (forcibly) test it on the rest of us, with God knows what effects, and to the ever greater profit of Big Pharma.
Might that latter benefit explain, in part, why “our free press” has blacked out what appears to be some good news about the coronavirus crisis? Is not our fear of the disease more valuable than any means of treating it—valuable not just to Merck et al., but to the state that’s slowly cracking down on all the rest of us in this emergency (which would be over, if there really is a cure)?
Please send this far and wide; and let us hope this news is true, that chloroquine can cure this illness—and that we then can find a larger cure for “our free press,” whose censorship and lies are also killing us.
From Dick Atlee:
I’ve sent the following to the various medically-related people I know, and
I hope you all will consider sharing it with your medical people (and
friends and relatives). As I say in the note, it will be very interesting
to see how this plays out against the vaccine-rush backdrop.
In a similar vein, the links at the end to the promising Chinese high-dose
IV vitamin C studies will undoubtedly be censored by Facebook as false
information. As pointed out in one of the articles, the irony is that
Facebook itself is censored in China, so their censorship of Vitamin C will
not be felt there, while the Chinese government is not censoring such info
(get your mind around THAT double negative :-)).
——– Forwarded Message ——–
It might be useful for you going forward to be aware of the following very
good news. It is an excerpt (clumsy translation) I encountered today from a
speech last week by a renowned French infectious disease researcher, Didier
Raoult. I found his latest paper on this (Feb 15) at
Apparently the Chinese, with an obviously major problem on their hands,
have been researching existing “safe” drugs and have found one that cures
the Coronavirus infection very easily: the anti-malarial Chloroquine.
Didier comments: “[O]f all respiratory infections [Covid-19 is now]
probably the easiest to treat.”
This will basically sideline the billions of $ headed for a vaccine, which
may make this news a bit hard to come by in the West. It will be
interesting to watch. But at least it gives medical people who are aware of
it a powerful tool.
From Didier Raoult:
Well, here is a last minute scoop, a very important news. The Chinese, who
are the fastest and who are very pragmatic, instead of looking to develop a
new vaccine or a new molecule that could treat the coronavirus, they did
what we call ‘repositioning,’ meaning they tested old molecules that are
known and have been used in the past without showing toxic effects, to see
if they could use some to treat the new coronavirus. They tested them for
their new virus and found, just as it was found and forgotten for the SARS
virus, Cloroquine is active in vitro, had been interviewed by the Chinese
I had been asked what advice I would give to the Chinese and what I was
expecting from them. As I think they have the best virologist teams in the
world, I had told them ‘I hope that your researchers will be very fast to
prove the efficacy of Chloroquine on Coronaviruses’. And now it’s done! It’s
efficient on the Coronavirus. 500mg of Chloroquine per day during 10 days
brings a spectacular improvement and is recommended for all clinical cases
that tested positive for Coronaviruses.
It’s excellent news. Actually, of all respiratory infections it’s
probably the easiest to treat. So there is really no reason to get excited
anymore. There is really no reason to get excited and rush to produce a
vaccine. One just needs to work and look at which licensed molecules are
potentially active and can be of immediate use. Now at this stage, of
course, there soon could be a rush for Chloroquine in pharmacies.
More from Dick Atlee:
Also of interest, concerning the treatment of the Acute Respiratory DistressSyndrome (ARDS) which is caused by the cytokine storm that can resultfrom coronavirus infection, and is the primary cause of death:China Treating Coronavirus COVID-19 with Intravenous Vitamin C
Report from China: Three Intravenous Vitamin C Research Studies Approved
for Treating COVID-19
Andrew W. Saul
21 February 2020
Orthomolecular Medicine News Service
Early Large Dose Intravenous Vitamin C is the Treatment of Choice for
Richard Z Cheng, MD, PhD; Hanping Shi, MD, PhD; Atsuo Yanagisawa, MD, PhD;
Thomas Levy, MD, JD; Andrew Saul, PhD.
Orthomolecular Medicine News Service
Feb 16, 2020